Moxibustion combined with chemotherapy inhibits gastric cancer growth by modulating the immunosuppressive microenvironment involving the Treg/IL-10/TGF-β1 axis
Yong Wu, Li Ma, Mengying Mao, Yuling Leng, Xianyang Zhou, Heng Xu, Yanqi Ding, Wanrong Hao, Wanhui Dong, Yonglei Zeng · 2025
Read Moxibustion combined with chemotherapy inhibits gastric cancer growth by modulating the immunosuppressive microenvironment involving the Treg/IL-10/TGF-β1 axis by Yong Wu, Li Ma, Mengying Mao, Yuling Leng, Xianyang Zhou, Heng Xu, Yanqi Ding, Wanrong Hao, Wanhui Dong, Yonglei Zeng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12719506.txt.
Description
Yong Wu and nine co-authors present a 2025 study on combining moxibustion with chemotherapy against stomach cancer. Moxibustion is a traditional treatment that warms acupuncture points with burning herbs. Tumors often shield themselves with an immune-suppressing environment, which blunts therapy. The team paired data analysis with mouse experiments to test whether the combined treatment reshapes that shield.
Two immune signals tied to suppression ran high in stomach tumors and linked to worse outlooks. In mice, the combination slowed tumor growth most, cutting it by nearly half. It also lowered suppressor cells and their signals in the blood while raising killer T cells inside tumors. The authors describe a two-way effect: less suppression and stronger attack at once. They present the pairing as a model for joining traditional and Western cancer care.
Catalog record
| CREATOR | Yong Wu, Li Ma, Mengying Mao, Yuling Leng, Xianyang Zhou, Heng Xu, Yanqi Ding, Wanrong Hao, Wanhui Dong, Yonglei Zeng |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |